Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GEORGE K RAFEEDIE

Allopathic & Osteopathic Physicians Family Medicine

NPI
1518196732
CMS profile
68807
Location
SNELLVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$2,212.61

143 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,212.61 143

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GEORGE K RAFEEDIE

NPI 1518196732 · CMS profile ID 68807

Allopathic & Osteopathic Physicians / Family Medicine

SNELLVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1518196732?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GEORGE K RAFEEDIE, NPI 1518196732, CMS profile ID 68807. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1518196732?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). GEORGE K RAFEEDIE, NPI 1518196732, CMS profile ID 68807. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1518196732?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
GEORGE K RAFEEDIE, NPI 1518196732, CMS profile ID 68807, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 143 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1518196732?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

143 matching records · $2,212.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 143 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 143.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $18.4208/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125104234 CMS
ABBVIE INC. $19.0008/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347797 CMS
AstraZeneca Pharmaceuticals LP $17.2408/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105259584 CMS
Novo Nordisk Inc $9.9108/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097391248 CMS
Otsuka America Pharmaceutical, Inc. $28.1408/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118965499 CMS
Sumitomo Pharma America, Inc. $29.3008/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148906851 CMS
ABBVIE INC. $3.7308/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347793 CMS
ABBVIE INC. $14.0208/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347789 CMS
Novo Nordisk Inc $2.7108/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096901791 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.7108/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086117828 CMS
ABBVIE INC. $4.1907/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347785 CMS
Azurity Pharmaceuticals, Inc. $21.1307/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134011413 CMS
GlaxoSmithKline, LLC. $26.4707/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116594684 CMS
ABBVIE INC. $7.7707/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347781 CMS
SHIELD THERAPEUTICS INC $21.1307/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150138389 CMS
ABBVIE INC. $5.2507/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347776 CMS
Novo Nordisk Inc $17.3907/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096669236 CMS
Vanda Pharmaceuticals Inc. $14.4707/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133917229 CMS
Abbott Laboratories $18.6007/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125104232 CMS
PFIZER INC. $18.0807/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132034580 CMS
ABBVIE INC. $5.0907/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347773 CMS
Novo Nordisk Inc $9.6106/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096600335 CMS
PFIZER INC. $23.1006/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131646787 CMS
ABBVIE INC. $17.9006/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347769 CMS
GlaxoSmithKline, LLC. $17.2806/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116676829 CMS
Teva Pharmaceuticals USA, Inc. $25.8206/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151621567 CMS
PFIZER INC. $8.8806/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132027777 CMS
ABBVIE INC. $4.4406/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347765 CMS
E.R. Squibb & Sons, L.L.C. $19.2306/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101415491 CMS
PFIZER INC. $8.5506/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132027775 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.0906/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153584853 CMS
ABBVIE INC. $4.8705/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347761 CMS
AstraZeneca Pharmaceuticals LP $15.5305/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104672039 CMS
Phadia US Inc. $21.7505/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1067579048 CMS
Otsuka America Pharmaceutical, Inc. $23.0005/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118965497 CMS
Abbott Laboratories $19.2305/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125104230 CMS
Sumitomo Pharma America, Inc. $28.4205/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148906849 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.1705/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118040626 CMS
Novo Nordisk Inc $18.4405/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097560774 CMS
Linus Health, Inc. $9.6405/02/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155108081 CMS
Novo Nordisk Inc $19.2505/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097639980 CMS
Novo Nordisk Inc $1.4505/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097804076 CMS
ABBVIE INC. $1.8505/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347757 CMS
Lilly USA, LLC $24.9205/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134985292 CMS
ABBVIE INC. $7.8304/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105347753 CMS
Otsuka America Pharmaceutical, Inc. $23.0004/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118965495 CMS
PFIZER INC. $9.7604/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132027773 CMS
Novo Nordisk Inc $18.8804/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097704072 CMS
PFIZER INC. $16.9504/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131410593 CMS
Teva Pharmaceuticals USA, Inc. $19.5704/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151621531 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $554.15 35
PY2020 $648.30 46
PY2021 $1,462.12 122
PY2022 $1,796.45 147
PY2023 $1,888.60 146
PY2024 $2,212.61 143
PY2025 $2,915.04 200

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $152,350.15 6
PY2024 Recipient $4,583.55 2
PY2024 Principal investigator $16,367.07 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alnylam Pharmaceuticals Inc. $6,000.00 12/05/2025 Non-covered Recipient Entity
Georgia Clinical Research
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508207
Principal investigator 1 Alnylam Pharmaceuticals Inc. $3,000.00 12/05/2025 Non-covered Recipient Entity
Georgia Clinical Research
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508211
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $35.00 09/05/2025 Non-covered Recipient Entity
GEORGIA CLINICAL RESEARCH LLC
PAS576 No dispute reported 06/30/2026 1192299537
Principal investigator 1 Eli Lilly and Company $113,010.00 04/08/2025 Non-covered Recipient Entity
GEORGIACLINICAL RESEARCH LLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1187881690
Principal investigator 1 Eli Lilly and Company $25,748.00 03/04/2025 Non-covered Recipient Entity
GEORGIACLINICAL RESEARCH LLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1187881786
Principal investigator 1 Eli Lilly and Company $4,557.15 02/25/2025 Non-covered Recipient Entity
NORTH GEORGIA CLINICAL RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) No dispute reported 06/30/2026 1187886468